Spear Bio plans to use the technology to build a protein detection platform and an assay that can measure levels of neutralizing antibodies against SARS-CoV-2.
Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute's DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup.
Wyss Institute at Harvard University, Aug. 23, 2022 (GLOBE NEWSWIRE) (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc. announced that
/PRNewswire/ Pharmaceutical drug developers and healthcare researchers need innovative tools to understand COVID-19 immune response and validate vaccines.